Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)
Clinical trial NCT03180619 · COMPLETED
Trial details
- NCT number
- NCT03180619
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-29
- Primary completion
- 2019-03-27
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.